All Studies

Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer.

Z-ligustilide+cisplatin combination inhibits phospholipid synthesis by upregulating PLPP1, inducing cell cycle arrest and apoptosis in cisplatin-resistant lung cancer cells by inhibiting AKT activation. Potential promising approach for cisplatin-resistant tumors.

Geng P et al (2023).
Int J Mol Sci.
PubMed:
38069368

The Chemical Profile, Antioxidant, and Anti-Lipid Droplet Activity of Fluid Extracts from Romanian Cultivars of Haskap Berries, Bitter Cherries, and Red Grape Pomace for the Management of Liver Steatosis.

Craciunescu O et al (2023).
Int J Mol Sci.
PubMed:
38069172